Farallon Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134M | Buy |
|
|||||
|
2025
Q1 | $154M | Buy |
|
|||||
|
2024
Q4 | $208M | Buy |
|
|||||
|
2024
Q3 | $59.4M | Buy |
|
|||||
|
2024
Q2 | $22.3M | Buy |
|
|||||
|
2024
Q1 | $234K | Sell |
|
|||||
|
2023
Q4 | $4.37M | Sell |
|
|||||
|
2023
Q3 | $10.8M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.86M | Sell |
|
|||||
|
2018
Q3 | $4.06M | Buy |
|